Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Hematology

Symptoms, Emergencies, and Warning Signs of WM

At a Glance

New vision changes, heavy nose or gum bleeding, sudden confusion, severe headache, weakness, seizures, or severe breathlessness in Waldenström macroglobulinemia may signal a life-threatening complication. Call 911 immediately and tell emergency staff that you have WM and may have hyperviscosity.

Living with Waldenström macroglobulinemia (WM) requires a careful balance of awareness. Because the disease often moves slowly, many of the symptoms you experience will be manageable and stable over long periods. However, the high levels of IgM protein in your blood can sometimes cause sudden, serious complications that require immediate medical attention.

Routine Symptoms: Living with the “Slow” Side of WM

Most symptoms of WM develop gradually. These are generally not emergencies, but they are important to track and discuss with your hematologist during your regular visits.

  • Anemia and Fatigue: The most common symptom of WM is fatigue caused by anemia (low red blood cell count) [1]. This happens when lymphoma cells crowd out healthy blood-forming cells in your bone marrow [2]. While profound exhaustion is frustrating, new or rapidly worsening fatigue should never be ignored, as it could reflect marked anemia, bleeding, or infection, and should prompt a call to your team [3].
  • Peripheral Neuropathy: About half of all WM patients experience neuropathy—numbness, tingling, or “pins and needles” usually starting in the feet or hands [4]. This is often caused by IgM-associated antibodies (such as anti-MAG) affecting your nerves, though other causes like diabetes or medications must also be evaluated [5].
  • Cold-Related Issues: Some patients have cold agglutinin disease or cryoglobulinemia. These are distinct conditions that can occur when you are exposed to cold temperatures [6][7]. This can lead to:
    • Pain or blue/purple discoloration in your fingers, toes, or nose (Raynaud phenomenon) [8].
    • Skin sores or ulcers [7].
    • Joint pain or kidney issues [8].
      (Note: Cold agglutinin disease involves antibody-mediated red blood cell destruction (hemolysis), which can cause dark urine, jaundice, or severe anemia [6]. Cryoglobulinemia involves IgM precipitating in the cold, causing severe vessel inflammation.)

When It Is an Emergency: Hyperviscosity Syndrome (HVS)

The most critical emergency in WM is Hyperviscosity Syndrome (HVS). This occurs when your blood becomes so thick with IgM protein that it can no longer flow easily through small blood vessels [9]. HVS is a life-threatening oncologic emergency that requires immediate hospitalization for a procedure called plasma exchange (plasmapheresis) to temporarily remove the excess IgM and lower the blood’s viscosity [9][10].

Seek emergency care immediately (Call 911) if you experience these “Red Flags”:

  1. Mucosal Bleeding: Unusual, heavy, persistent, or unexplained mucosal bleeding from the nose, gums, or other areas [9][11].
  2. Visual Changes: Blurred vision, “spots” in your vision, or a sudden loss of sight. A doctor must perform a fundoscopic exam to look for “sausaging” or hemorrhages in the blood vessels at the back of your eye [9][12].
  3. Neurologic Crisis: Sudden, severe confusion, marked sleepiness, severe headache, dizziness, new seizures, sudden weakness, loss of coordination (ataxia), or a feeling of “fainting” [13].
  4. Shortness of Breath: Sudden, severe difficulty breathing [14].

Rare but Serious Complications

There are two other serious conditions that, while rare, require prompt specialist evaluation or emergency care:

Bing-Neel Syndrome (BNS)
This occurs when WM cells cross into the central nervous system (the brain and spinal cord) [15]. BNS can happen even if your blood tests look stable [16]. Symptoms include:

  • New, severe headaches or seizures [17].
  • Sudden changes in personality or memory [15].
  • Weakness or loss of balance that makes walking difficult [18].
    These symptoms warrant immediate emergency evaluation.

Cryoglobulinemic Vasculitis
If cryoglobulins cause severe inflammation in your blood vessels (vasculitis), it can damage your organs [19]. Watch for “palpable purpura” (raised purple spots on the skin that you can feel), sudden swelling in your legs, or a significant change in how much you urinate, which could indicate kidney damage [8][20].

Knowing the Difference

It is natural to worry when you feel a new symptom. Remember that a slow rise in your IgM levels on a lab report is usually not an emergency if you feel fine. However, new visual changes, new confusion, or active mucosal bleeding are always reasons to call 911 or go to the nearest emergency room [9]. Always tell the emergency staff: “I have Waldenström macroglobulinemia, a blood cancer, and I am concerned about hyperviscosity.” Do not wait for a laboratory viscosity result if your symptoms are compelling.

Common questions in this guide

Which WM symptoms mean I should call 911?
Call 911 for heavy or persistent nose or gum bleeding, sudden vision changes, severe confusion, a severe headache, new weakness, seizures, loss of coordination, fainting, or severe shortness of breath. These symptoms can signal hyperviscosity syndrome or another serious complication. Tell emergency staff that you have Waldenström macroglobulinemia and are concerned about hyperviscosity.
What is hyperviscosity syndrome in WM, and how is it treated?
Hyperviscosity syndrome happens when excess IgM makes the blood unusually thick, so it cannot move easily through small blood vessels. It is a life-threatening emergency treated in the hospital with plasma exchange, also called plasmapheresis, which temporarily removes excess IgM and lowers blood thickness.
Is gradually worsening fatigue or numbness always an emergency in WM?
Fatigue from anemia and peripheral neuropathy with numbness or tingling are common and often develop gradually. New or rapidly worsening fatigue, spreading numbness, weakness, or difficulty using your hands should be reported promptly because marked anemia, bleeding, infection, or another cause may need evaluation.
Could my symptoms be Bing-Neel syndrome even if my blood tests are stable?
Yes. Bing-Neel syndrome occurs when WM cells enter the brain or spinal cord and can cause new severe headaches, seizures, personality or memory changes, weakness, or trouble with balance even when blood tests appear stable. These symptoms need immediate emergency evaluation.
What cold-related changes should I report?
Cold agglutinin disease and cryoglobulinemia can cause painful or blue-purple fingers, toes, or nose, skin sores, joint pain, or other cold-triggered symptoms. Dark urine or jaundice may indicate red blood cell destruction, while reduced urination or kidney problems need prompt medical attention. Ask your hematology team about cold-weather precautions.
Does a rising IgM or serum viscosity result always mean I have an emergency?
A slow rise in IgM without symptoms is usually not an emergency, and your hematology team can explain your serum viscosity and the level that concerns them. However, do not wait for a laboratory result if you have new vision changes, confusion, active mucosal bleeding, or severe breathing difficulty; call 911.
What signs may indicate cryoglobulinemic vasculitis?
Raised purple spots that you can feel, sudden leg swelling, or a major change in how much you urinate can occur when cryoglobulins inflame blood vessels. These signs may indicate organ damage, including kidney injury, and require prompt specialist or emergency evaluation.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Waldenström macroglobulinemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If I experience heavy mucosal bleeding or severe confusion, which emergency room should I go to for immediate evaluation and plasma exchange?
  2. 2.What was my serum viscosity at my last check, and at what level would you become concerned about hyperviscosity?
  3. 3.How can we distinguish my routine neuropathy from something more serious like Bing-Neel syndrome or cryoglobulinemia?
  4. 4.Are there specific cold-weather precautions I should take to manage my cold agglutinin or cryoglobulinemia symptoms?
  5. 5.Do you have a protocol in place for a 'rituximab flare' to ensure my IgM levels don't spike dangerously during treatment?

References

References (20)
  1. 1

    Diagnosis and Risk Stratification in Waldenström Macroglobulinemia.

    Zanwar S, Kapoor P

    Journal of the National Comprehensive Cancer Network : JNCCN 2024; (22(7)).

    PMID: 39236757
  2. 2

    Waldenström Macroglobulinemia: 2025 Update on Diagnosis, Risk Stratification, and Management.

    Gertz MA

    American journal of hematology 2025; (100(6)):1061-1073 doi:10.1002/ajh.27666.

    PMID: 40095219
  3. 3

    SOHO State of the Art Updates and Next Questions: Waldenström Macroglobulinemia - 2021 Update on Management and Future Directions.

    Thomas SK

    Clinical lymphoma, myeloma & leukemia 2022; (22(6)):347-355 doi:10.1016/j.clml.2021.11.014.

    PMID: 34980578
  4. 4

    Investigation and Management of Immunoglobulin M- and Waldenström-Associated Peripheral Neuropathies.

    Tomkins O, Leblond V, Lunn MP, et al.

    Hematology/oncology clinics of North America 2023; (37(4)):761-776 doi:10.1016/j.hoc.2023.04.007.

    PMID: 37385714
  5. 5

    A Focus on Waldenström Macroglobulinemia and AL Amyloidosis.

    Lu R, Richards T

    Journal of the advanced practitioner in oncology 2022; (13(Suppl 4)):45-56 doi:10.6004/jadpro.2022.13.5.14.

    PMID: 35937468
  6. 6

    Diagnosis and management of cold agglutinin disease.

    Berentsen S

    Hematology. American Society of Hematology. Education Program 2025; (2025(1)):295-304 doi:10.1182/hematology.2025000718.

    PMID: 41348049
  7. 7

    Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia.

    Sidana S, Rajkumar SV, Dispenzieri A, et al.

    American journal of hematology 2017; (92(7)):668-673 doi:10.1002/ajh.24745.

    PMID: 28370486
  8. 8

    Clinical characteristics and treatment outcome of type I cryoglobulinemia in Chinese patients: a single-center study of 45 patients.

    Zhang LL, Cao XX, Shen KN, et al.

    Annals of hematology 2020; (99(8)):1735-1740 doi:10.1007/s00277-020-04123-1.

    PMID: 32535708
  9. 9

    Hyperviscosity Syndrome: An Oncologic Emergency.

    Bey T, Qdaisat A

    Emergency medicine clinics of North America 2025; (43(3)):445-452 doi:10.1016/j.emc.2025.03.001.

    PMID: 40610061
  10. 10

    Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

    Kapoor P, Ansell SM, Fonseca R, et al.

    JAMA oncology 2017; (3(9)):1257-1265 doi:10.1001/jamaoncol.2016.5763.

    PMID: 28056114
  11. 11

    Bleeding Propensity in Waldenström Macroglobulinemia: Potential Causes and Evaluation.

    Brysland SA, Maqbool MG, Talaulikar D, Gardiner EE

    Thrombosis and haemostasis 2022; (122(11)):1843-1857 doi:10.1055/a-1896-7092.

    PMID: 35817084
  12. 12

    The Spectrum of Ocular Manifestations in Patients with Waldenström's Macroglobulinemia.

    Dammacco R, Lisch W, Kivelä TT, et al.

    Ocular immunology and inflammation 2022; (30(7-8)):1659-1668 doi:10.1080/09273948.2021.1933068.

    PMID: 34270382
  13. 13

    Cold agglutination as a pivotal diagnostic clue for Waldenström macroglobulinemia: A rare case report with diagnostic and therapeutic insights.

    Zhang W, Xia Y, Yang Z, et al.

    Experimental and therapeutic medicine 2026; (32(2)):217 doi:10.3892/etm.2026.13212.

    PMID: 42389444
  14. 14

    Outcomes of patients with Waldenström macroglobulinemia in ICU: a retrospective multicentric study.

    Barraud C, Velletrie A, Harel S, et al.

    Journal of critical care 2026; (97()):155731 doi:10.1016/j.jcrc.2026.155731.

    PMID: 42667736
  15. 15

    Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome.

    Minnema MC, Kimby E, D'Sa S, et al.

    Haematologica 2017; (102(1)):43-51 doi:10.3324/haematol.2016.147728.

    PMID: 27758817
  16. 16

    Central Nervous System Involvement by Waldenstrom Macroglobulinemia: A Case Report of the Bing-Neel Syndrome.

    Arjunan A, Rai H

    Case reports in hematology 2019; (2019()):4075960 doi:10.1155/2019/4075960.

    PMID: 31001436
  17. 17

    Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.

    Castillo JJ, D'Sa S, Lunn MP, et al.

    British journal of haematology 2016; (172(5)):709-15 doi:10.1111/bjh.13883.

    PMID: 26686858
  18. 18

    Successful treatment with tirabrutinib for relapsed lymphoplasmacytic lymphoma complicated by Bing-Neel syndrome.

    Saburi M, Saburi Y, Kawano K, et al.

    International journal of hematology 2022; (115(4)):585-589 doi:10.1007/s12185-021-03246-z.

    PMID: 34699012
  19. 19

    Clinical and clonal characteristics of monoclonal immunoglobulin M-associated type I cryoglobulinaemia.

    Khwaja J, Vos JMI, Pluimers TE, et al.

    British journal of haematology 2024; (204(1)):177-185 doi:10.1111/bjh.19112.

    PMID: 37726004
  20. 20

    Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.

    Higgins L, Nasr SH, Said SM, et al.

    Clinical journal of the American Society of Nephrology : CJASN 2018; (13(7)):1037-1046 doi:10.2215/CJN.13041117.

    PMID: 29848505

This page is for informational purposes only and does not constitute medical advice. It explains WM warning signs for patients and caregivers, but your hematology team should guide decisions about your symptoms; call 911 for severe or sudden red-flag symptoms.